Zeitschriftenartikel (248)
41.
Zeitschriftenartikel
38 (5), S. 238 - 238 (2005)
Is testosterone a substrate of P-glycoprotein in abcb1ab knock out mice? Pharmacopsychiatry 42.
Zeitschriftenartikel
16 (3), S. 345 - 349 (2005)
The directions of psychiatric research by Emil Kraepelin. History of Psychiatry 43.
Zeitschriftenartikel
38 (5), S. 240 - 240 (2005)
Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: is there any evidence for the continuum hypothesis? Pharmacopsychiatry 44.
Zeitschriftenartikel
38 (5), S. 240 - 240 (2005)
Responsiveness of the hypothalamic-pituitary-adrenocortical system in patients with agoraphobia and panic attacks. Pharmacopsychiatry 45.
Zeitschriftenartikel
16 (Suppl. 1), S. S88 - S88 (2005)
A key role for hypothalamic AVP in anxiety/depression-related behavior and social recognition: An antisense study. Behavioural Pharmacology 46.
Zeitschriftenartikel
38 (5), S. 241 - 242 (2005)
Sleep architecture and sleep continuity in healthy twins. Pharmacopsychiatry 47.
Zeitschriftenartikel
38 (5), S. 242 - 242 (2005)
The hormonal hypothesis of RLS revisited - prevalence of RLS in transsexuals. Pharmacopsychiatry 48.
Zeitschriftenartikel
38 (5), S. 249 - 249 (2005)
Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Pharmacopsychiatry 49.
Zeitschriftenartikel
38 (5), S. 249 - 249 (2005)
Ghrelin plasma levels during psychopharmacological treatment. Pharmacopsychiatry 50.
Zeitschriftenartikel
38 (5), S. 248 - 249 (2005)
Does antidepressant therapy improve glucose metabolism? Pharmacopsychiatry 51.
Zeitschriftenartikel
38 (5), S. 251 - 251 (2005)
Change in HPA system function predicts treatment response in depression. Pharmacopsychiatry 52.
Zeitschriftenartikel
38 (5), S. 251 - 251 (2005)
Altered short-term and long-term plasticity in the dentate gyrus in mice lacking the cannabinoid CB1 receptor. Pharmacopsychiatry 53.
Zeitschriftenartikel
38 (5), S. 253 - 253 (2005)
Effects of the metabotropic glutamate type II receptor agonist LY544344 on panic anxiety induced by cholecystokinin tetrapeptide in healthy volunteers. Pharmacopsychiatry 54.
Zeitschriftenartikel
16 (Suppl. 1), S. S88 - S88 (2005)
Major role for vasopressin in a new mouse model of anxiety and depression. Behavioural Pharmacology 55.
Zeitschriftenartikel
38 (5), S. 254 - 254 (2005)
Proteomic search for intracellular binding sites of antidepressants. Pharmacopsychiatry 56.
Zeitschriftenartikel
38 (5), S. 254 - 254 (2005)
Implications of obesity and medical illness for major depression - a different endophenotype of major depression in obese patients? Pharmacopsychiatry 57.
Zeitschriftenartikel
38 (5), S. 255 - 255 (2005)
Sleep-onset REM sleep in obsessive compulsive disorder. Pharmacopsychiatry 58.
Zeitschriftenartikel
38 (5), S. 259 - 259 (2005)
Effects of TPR proteins on steroid receptor signaling. Pharmacopsychiatry 59.
Zeitschriftenartikel
38 (5), S. 260 - 260 (2005)
MAO-B acitivity in platelets associated with suicide attempts in depressed patients. Pharmacopsychiatry 60.
Zeitschriftenartikel
38 (5), S. 261 - 261 (2005)
Site-specific overexpression of corticotropin-releasing hormone (CRH) in the mouse brain - modelling central CRH system hyperactivity. Pharmacopsychiatry